0001437749-22-020845.txt : 20220817 0001437749-22-020845.hdr.sgml : 20220817 20220817172217 ACCESSION NUMBER: 0001437749-22-020845 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220815 FILED AS OF DATE: 20220817 DATE AS OF CHANGE: 20220817 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Furlow Brenda S. CENTRAL INDEX KEY: 0001443851 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-17272 FILM NUMBER: 221175334 MAIL ADDRESS: STREET 1: 614 MCKINLEY PLACE NE CITY: MINNEAPOLIS STATE: MN ZIP: 55413 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIO-TECHNE Corp CENTRAL INDEX KEY: 0000842023 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 411427402 STATE OF INCORPORATION: MN FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 614 MCKINLEY PL N E CITY: MINNEAPOLIS STATE: MN ZIP: 55413 BUSINESS PHONE: 6123798854 MAIL ADDRESS: STREET 1: 614 MCKINLEY PLACE NE CITY: MINNEAPOLIS STATE: MN ZIP: 55413 FORMER COMPANY: FORMER CONFORMED NAME: TECHNE CORP /MN/ DATE OF NAME CHANGE: 19920703 4 1 rdgdoc.xml FORM 4 X0306 4 2022-08-15 0000842023 BIO-TECHNE Corp TECH 0001443851 Furlow Brenda S. 614 MCKINLEY PLACE NE MINNEAPOLIS MN 55413 1 SVP - General Counsel Common Stock 6523 D Common Stock 1330 I By Trust #1 Common Stock 1330 I By Trust #2 Stock Options (Right to Buy) 378.08 2022-08-15 4 A 0 6166 0 A 2029-08-15 Common Stock 6166 6166 D Restricted Stock Units 2022-08-15 4 A 0 1984 0 A Common Stock 1984 1984 D Stock Options (Right to Buy) 177.3200 2025-08-08 Common Stock 16562 16562 D Stock Options (Right to Buy) 190.4100 2026-08-07 Common Stock 9968 9968 D Stock Options (Right to Buy) 190.4100 2026-08-07 Common Stock 13290 13290 D Restricted Stock Units Common Stock 1679 1679 D Stock Options (Right to Buy) 267.8700 2027-08-05 Common Stock 7492 7492 D Stock Options (Right to Buy) 267.8700 2027-08-05 Common Stock 9990 9990 D Stock Options (Right to Buy) 267.8700 2027-08-05 Common Stock 8325 8325 D Stock Options (Right to Buy) 267.8700 2027-08-05 Common Stock 8325 8325 D Stock Options (Right to Buy) 372.4400 2022-08-31 2028-03-01 Common Stock 10997 10997 D Restricted Stock Units Common Stock 1167 1167 D Stock Options (Right to Buy) 481.8200 2028-08-06 Common Stock 4560 4560 D Stock Options (Right to Buy) 481.8200 2028-08-06 Common Stock 6080 6080 D Stock Options (Right to Buy) 125.0500 2024-08-09 Common Stock 9503 9503 D Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. Options to purchase 1,542 shares vest on each of 8/15/2023 and 8/15/2025 and options to purchase 1,541 shares vest on 8/15/2024 and 8/15/2026. 661 shares vest on each of 8/15/2023 and 8/15/2025, and 662 shares vest on 8/15/2024. Fully exercisable. On 8/7/22, the Board of Directors certified vesting of 1,969 performance RSUs. Options to purchase 3,323 shares vest on each of 8/7/2020 and 8/7/2021 and options to purchase 3,322 shares vest on each of 8/7/2022 and 8/7/2023. Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). Options to purchase 2,497 shares vest on each of 8/5/2021 and 8/5/2022 and options to purchase 2,498 shares vest on each of 8/5/2023 and 8/5/2024. Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021. Options to purchase 2,775 shares vest on each of 8/5/2021, 8/5/2022 and 8/5/2023. Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). Options to purchase 1,520 shares vest on each of 8/6/2022, 8/6/2023, 8/6/2024 and 8/6/2025. /s/ Andrew Nick as Attorney-in-Fact for Brenda S. Furlow pursuant to Power of Attorney previously filed. 2022-08-17